The role of oxidative stress in the pathophysiology of hypertension - PubMed (original) (raw)
Review
doi: 10.1038/hr.2010.264. Epub 2011 Jan 13.
Affiliations
- PMID: 21228777
- DOI: 10.1038/hr.2010.264
Review
The role of oxidative stress in the pathophysiology of hypertension
Ramón Rodrigo et al. Hypertens Res. 2011 Apr.
Abstract
Hypertension is considered to be the most important risk factor in the development of cardiovascular disease. An increasing body of evidence suggests that oxidative stress, which results in an excessive generation of reactive oxygen species (ROS), has a key role in the pathogenesis of hypertension. The modulation of the vasomotor system involves ROS as mediators of vasoconstriction induced by angiotensin II, endothelin-1 and urotensin-II, among others. The bioavailability of nitric oxide (NO), which is a major vasodilator, is highly dependent on the redox status. Under physiological conditions, low concentrations of intracellular ROS have an important role in the normal redox signaling maintaining vascular function and integrity. However, under pathophysiological conditions, increased levels of ROS contribute to vascular dysfunction and remodeling through oxidative damage. In human hypertension, an increase in the production of superoxide anions and hydrogen peroxide, a decrease in NO synthesis and a reduction in antioxidant bioavailability have been observed. In turn, antioxidants are reducing agents that can neutralize these oxidative and otherwise damaging biomolecules. The use of antioxidant vitamins, such as vitamins C and E, has gained considerable interest as protecting agents against vascular endothelial damage. Available data support the role of these vitamins as effective antioxidants that can counteract ROS effects. This review discusses the mechanisms involved in ROS generation, the role of oxidative stress in the pathogenesis of vascular damage in hypertension, and the possible therapeutic strategies that could prevent or treat this disorder.
Similar articles
- Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
Touyz RM. Touyz RM. Hypertension. 2004 Sep;44(3):248-52. doi: 10.1161/01.HYP.0000138070.47616.9d. Epub 2004 Jul 19. Hypertension. 2004. PMID: 15262903 Review. - Oxidative stress and antioxidants in hypertension-a current review.
Sinha N, Dabla PK. Sinha N, et al. Curr Hypertens Rev. 2015;11(2):132-42. doi: 10.2174/1573402111666150529130922. Curr Hypertens Rev. 2015. PMID: 26022210 Review. - Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
Montezano AC, Touyz RM. Montezano AC, et al. Can J Cardiol. 2012 May;28(3):288-95. doi: 10.1016/j.cjca.2012.01.017. Epub 2012 Mar 23. Can J Cardiol. 2012. PMID: 22445098 Review. - Role of mitochondrial oxidative stress in hypertension.
Dikalov SI, Ungvari Z. Dikalov SI, et al. Am J Physiol Heart Circ Physiol. 2013 Nov 15;305(10):H1417-27. doi: 10.1152/ajpheart.00089.2013. Epub 2013 Sep 16. Am J Physiol Heart Circ Physiol. 2013. PMID: 24043248 Free PMC article. Review. - Redox signaling in hypertension.
Paravicini TM, Touyz RM. Paravicini TM, et al. Cardiovasc Res. 2006 Jul 15;71(2):247-58. doi: 10.1016/j.cardiores.2006.05.001. Epub 2006 May 9. Cardiovasc Res. 2006. PMID: 16765337 Review.
Cited by
- Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure.
Yildirim A, Russell J, Yan LS, Senchenkova EY, Granger DN. Yildirim A, et al. Hypertension. 2012 Dec;60(6):1503-9. doi: 10.1161/HYPERTENSIONAHA.112.198465. Epub 2012 Oct 22. Hypertension. 2012. PMID: 23090770 Free PMC article. - Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.
Lillo-Moya J, Rojas-Solé C, Muñoz-Salamanca D, Panieri E, Saso L, Rodrigo R. Lillo-Moya J, et al. Antioxidants (Basel). 2021 Apr 25;10(5):667. doi: 10.3390/antiox10050667. Antioxidants (Basel). 2021. PMID: 33922912 Free PMC article. Review. - Effect of saffron supplementation on oxidative stress parameters: A systematic review and meta-analysis of randomized placebo-controlled trials.
Morvaridzadeh M, Agah S, Dulce Estêvão M, Hosseini AS, Heydari H, Toupchian O, Abdollahi S, Persad E, Abu-Zaid A, Rezamand G, Heshmati J. Morvaridzadeh M, et al. Food Sci Nutr. 2021 Aug 5;9(10):5809-5819. doi: 10.1002/fsn3.2463. eCollection 2021 Oct. Food Sci Nutr. 2021. PMID: 34646548 Free PMC article. Review. - Curcumin Nanoemulsion: Unveiling Cardioprotective Effects via ACE Inhibition and Antioxidant Properties in Hypertensive Rats.
Ishaq M, Khan MF, Verma G, Rathi A, Adil M, Faizan M, Najmi AK, Akhtar M, Al Kamaly O, Alshawwa SZ, Shahat AA, Alhalmi A. Ishaq M, et al. Medicina (Kaunas). 2023 Sep 29;59(10):1748. doi: 10.3390/medicina59101748. Medicina (Kaunas). 2023. PMID: 37893466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical